Freiraum Ventures
Early-stage fund of Strascheg Center for Entrepreneurship (SCE), Hochschule München
Also known as SCE Freiraum Ventures, SCE Projects GmbH, Freiraum
Munich early-stage fund of the Strascheg Center for Entrepreneurship (Munich University of Applied Sciences), backed by Falk F. Strascheg; €50k–200k first tickets in university-linked startups.
Run by SCE Projects GmbH at the Strascheg Center for Entrepreneurship (Munich University of Applied Sciences); not to be confused with other 'Freiraum' coworking or real-estate businesses.
- HEADQUARTERS
- Munich, Germany
- FOUNDED
- —
- AUM
- —
- OUTSIDE CAPITAL
- —
- TEAM LISTED
- 5 people
Focus
- STAGES
- Pre-SeedSeed
- ASSET MIX
- Venture capital
- GEOGRAPHY
- Germany
Overview
Freiraum Ventures (SCE Freiraum Ventures) is the early-stage fund attached to the Strascheg Center for Entrepreneurship (SCE), the entrepreneurship centre of the Munich University of Applied Sciences (Hochschule München). It is operated by SCE Projects GmbH in Munich and says its fund is backed by Prof. Dr. Falk F. Strascheg, the founder of the SCE and a long-time German venture capitalist. It invests EUR 50k to 200k in incorporated early-stage teams across sectors, aims to be the first investor, and adds coaching and SCE infrastructure. The site lists 17 portfolio startups.
Investment thesis
Backs early-stage, preferably university-linked teams across industries that have shown first steps, strong commitment and a scalable business model; wants to be the first investor and supports founders with knowledge, coaching and the SCE infrastructure (average ticket about €100k, average round €700k).
PORTFOLIO (17)
- Software & SaaS
- SYNSOR
- Fintech
- Mobility & Logistics
- HealthTech
- Biotech & Life Sciences
- Space
- GETFITHealthTech
- Artificial Intelligence
- HealthTech
- HealthTech
- Software & SaaS
- ONIC
- ORATIS
- HealthTech
- APONIA
- HealthTech
People
Links
Frequently asked questions
Freiraum Ventures is a VC fund based in Munich, Germany.
Yes. Freiraum Ventures invests its own capital in private companies.
Freiraum Ventures invests at Pre-Seed and Seed stages in HealthTech, Software & SaaS, Artificial Intelligence and Biotech & Life Sciences.
Freiraum Ventures's stated ticket size is €50K–€200K.
Key people at Freiraum Ventures include David Photien (Partner), Prof. Dr. Klaus Sailer (Partner; managing director of SCE Projects GmbH), Prof. Dr. Herbert Gillig (Partner) and Daniel Rasel (Investment Associate).
Freiraum Ventures's investments include ZERØTEC, SYNSOR, REFINQ, PANTOHEALTH, VODA, ONYX BIOTECH, ARCSPACE and GETFIT, among others.
Freiraum Ventures states that it accepts submissions through its official contact page.